For organ placement and donor suitability, contact:
1-866-731-6585
We are available 24/7.
For other inquiries, please contact:
(352) 273-8277
nPOD@pathology.ufl.edu
Pathology
Investigators in this group are using nPOD samples to try and understand the pathogenesis of type 1 diabetes.
Vitaly Ablamunits |
|---|
| Yale University |
Project: Comparison of total pancreatic insulin content and peripheral markers of beta cell function and destruction |
| Co-Investigators: Kevan Herold, M.D. Jasmin Lebastchi, M.D. |
| University of Florida |
Project 1: Pancreatic immunologic and metabolic parameters |
| Project 1 Principal Investigator: Martha Campbell-Thompson, D.V.M., Ph.D. |
| Project 2: Pancreatic duct glands in type 1 diabetes |
| Project 2 Principal Investigator: Peter Butler, M.D. |
Jeffrey Bluestone, Ph.D. |
|---|
| University of California, San Francisco |
Project: Vascular endothelial growth factor receptor signaling regulates the pathogenesis of type 1 diabetes |
Co-Investigator: |
| Joslin Diabetes Center and Harvard University |
Project: Joslin Medalist Study |
| Principal Investigator: George King, M.D. |
| University of California, San Francisco |
Project: Pancreatic duct glands in type 1 diabetes |
| Principal Investigator: Peter Butler, M.D. |
| University of California, San Francisco |
Project: Pancreatic duct glands in type 1 diabetes |
| Co-Investigator: Alexandra Butler, M.D. |
| University of Florida |
Project: Pancreatic immunologic and metabolic parameters |
Costanza Emanueli, Ph.D. |
|---|
| University of Bristol |
Project: Microangiopathy in diabetic bone marrow |
| Principal Investigator: Paolo Madeddu, M.D. |
| University of Colorado Health Science Center |
Project: Characterization of type 1 diabetes subsets |
Toshiaki Hanafusa, M.D., Ph.D. |
|---|
| Osaka University |
Project: Histological differences between Japanese and Western type 1 diabetes |
| Principal Investigator: Akihisa Imagawa, M.D., Ph.D., FACP |
Kevan Herold, M.D. |
|---|
| Yale University |
Project: Comparison of total pancreatic insulin content and peripheral markers of beta cell function and destruction |
| Principal Investigator: Vitaly Ablamunits |
Akihisa Imagawa, M.D., Ph.D., FACP |
|---|
| Osaka University |
Project: Histological differences between Japanese and Western type 1 diabetes |
| Co-Investigator: Toshiaki Hanafusa, M.D., Ph.D. |
Katherine Irvine, Ph.D. |
|---|
| University of Queensland |
Project: Pathological changes associated with chronic RelB activation in T1D |
| Principal Investigator: Ranjeny Thomas, MBBS, M.D. |
| Joslin Diabetes Center, Harvard University |
Project: Joslin Medalist Study |
| Co-Investigator: Susan Bonner-Weir, Ph.D. |
Eva Korpos, Ph. D. |
|---|
| University of Muenster |
Project: Leukocyte penetration of the peri-capsular basement membrane in human T1D |
| Principal Investigator: Lydia Sorokin, Ph.D. |
Jasmin Lebastchi, M.D. |
|---|
| Yale University |
Project: Comparison of total pancreatic insulin content and peripheral markers of beta cell function and destruction |
| Principal Investigator: Vitaly Ablamunits |
Paolo Maddedu, M.D. |
|---|
| University of Bristol |
Project: Microangiopathy in diabetic bone marrow |
| Co-Investigator: Costanza Emanueli, Ph.D. |
| University of Queensland, Australia |
Project: 3D structural characterization of human islet dysfunction/destruction |
Susan Perigo, Ph.D. |
|---|
| Benaroya Research Institute at Virginia Mason |
Project: Extracellular matrix involvement in type 1 diabetes pancreatic islet destruction |
| Principal Investigator: Thomas Wight, Ph.D. |
| University of Muenster |
Project: Leukocyte penetration of the peri-capsular basement membrane in human T1D |
| Co-Investigator: Eva Korpos, Ph.D. |
Scott Swenson, M.D., Ph.D. |
|---|
| Yale University School of Medicine |
Project: Polyploidy in the exocrine pancreas |
| University of Queensland |
Project: Pathological changes associated with chronic RelB activation in T1D |
| Co-Investigator: Katharine Irvine, Ph.D. |
Armando Villalta, Ph.D. |
|---|
| University of California, San Francisco |
Project: Vascular endothelial growth factor receptor signaling regulates the pathogenesis of type 1 diabetes |
| Principal Investigator: Jeffrey Bluestone, Ph.D. |
| Benaroya Research Institute at Virginia Mason |
Project: Extracellular matrix involvement in type 1 diabetes pancreatic islet destruction |
| Co-Investigator: Susan Perigo, Ph.D. |
*These investigators have received funding from the Juvenile Diabetes Research Foundation (JDRF).
